VALIDITY is a prospective, open-label, multicenter, randomized controlled trial (ClinicalTrials.gov number). The study was designed to evaluate the value of noninvasive anatomic CTA combined with functional CTP for the next clinical decision making and the added prognostic value of CTP beyond CTA.
Study Type
OBSERVATIONAL
Enrollment
1,748
Fuwai Hospital
Beijing, Beijing Municipality, China
RECRUITINGXiehe Hospital
Beijing, Beijing Municipality, China
RECRUITINGGuangdong General Hospital
Guangzhou, Guangdong, China
NOT_YET_RECRUITINGMACE
death, myocardial infarction and unstable angina requiring hospitalization
Time frame: 90 days, 6 months, 12 months, 24 months and 36 months
invasive coronary angiography and revascularization
invasive coronary angiography and PCI or CABG
Time frame: 90 days, 6 months, 12 months, 24 months and 36 months
he incidence of a composite of major complications from cardiovascular procedures and testing
stroke, bleeding, anaphylaxis, renal failure
Time frame: 90 days, 6 months, 12 months, 24 months and 36 months
Quality of Life
Quality of Life (QOL) as Measured by Seattle Angina Scale Anginal Frequency Subscale
Time frame: 90 days, 6 months, 12 months, 24 months and 36
total medical cost
Assess and compare total medical cost for the two diagnostic testing arms by intention to treat
Time frame: 90 days and 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Shanghai Sixth People's Hospital
Shanghai, China
RECRUITINGGeneral hospital of tianjin medical university
Tianjin, China
NOT_YET_RECRUITING